ORAL MUCOSITIS IN PATIENTS WITH CHEMOTHERAPY TREATMENT

被引:1
作者
Sciuca, Ana Maria [1 ]
Neamtu, Monica [2 ]
Marcu, Diana [4 ]
Costan, Victor Vlad [3 ]
Popa, Cristina [1 ]
机构
[1] Grigore T Popa Univ Med & Pharm, Oral Dermatol, Fac Med Dent, Discipline Oral Med, 16 Univ Str, Iasi 700115, Romania
[2] Grigore T Popa Univ Med & Pharm, Discipline Pharmacodynam & Clin Pharm, Fac Pharm, 16 Univ Str, Iasi 700115, Romania
[3] Grigore T Popa Univ Med & Pharm, Fac Med Dent, Discipline Oral & Maxillofacial Surg, 16 Univ Str, Iasi 700115, Romania
[4] Nicolae Testemitanu State Univ Med & Pharm, Dept Odontol Periodontol & Oral Pathol, Kishinev, Moldova
来源
ROMANIAN JOURNAL OF ORAL REHABILITATION | 2024年 / 16卷 / 01期
关键词
mucositis; chemotherapy; xerostomia; inflammation; bleeding; CLINICAL-PRACTICE GUIDELINES; INDUCED STOMATITIS; MANAGEMENT; CRYOTHERAPY; PREVENTION; RADIATION; AGENTS; TRIAL;
D O I
10.6261/RJOR.2024.1.16.43
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
In general terms, neoplastic conditions are characterized by increasing in cell proliferation and decreasing in cell apoptosis. The multiplication of atypical neoplastic cells, through their invasive capacity, leads to the infiltration of tissues or organs through the bloodstream or the lymphatic system. In this context, chemotherapy remains one of the most used treatment modalities, contrary to the progress made in recent years regarding the management of cancer in the Oro-Maxillo-Facial (OMF) sphere. This is applied either alone or associated with other therapeutic methods to block abnormal cell proliferation. The great inconvenience of chemotherapy is the lack of selectivity because it acts both on tumor cells and normal cells in the body. The oral cavity is very vulnerable to the direct and indirect toxic effects of chemotherapy. This fact is primarily due to local peculiarities that include: a high rate of mucosal cell turnover, the presence of a complex and diverse microflora in the oral cavity as well as the small traumatic injuries present as a result of the exercise of normal oral functions (mastication, swallowing, phonation).
引用
收藏
页码:452 / 460
页数:9
相关论文
共 27 条
  • [1] Management of dental patients taking common hemostasis-altering medications
    Aframian, Doron J.
    Lalla, Rajesh V.
    Peterson, Douglas E.
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2007, 103 (03): : S45 - S49
  • [2] Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients
    Aisa, Y
    Mori, T
    Kudo, M
    Yashima, T
    Kondo, S
    Yokoyama, A
    Ikeda, Y
    Okamoto, S
    [J]. SUPPORTIVE CARE IN CANCER, 2005, 13 (04) : 266 - 269
  • [3] [Anonymous], 2004, Human Genome Sciences Reports: Results Of Phase 2 Clinical Trial Of Repifermin
  • [4] Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis
    Barasch, Andrei
    Elad, Sharon
    Altman, Arnold
    Damato, Kathryn
    Epstein, Joel
    [J]. SUPPORTIVE CARE IN CANCER, 2006, 14 (06) : 528 - 532
  • [5] Bell Andrea, 2023, Oral Mucositis Last Update
  • [6] Management of Cancer Therapy-Associated Oral Mucositis
    Brown, Timothy J.
    Gupta, Arjun
    [J]. JCO ONCOLOGY PRACTICE, 2020, 16 (03) : 103 - 110
  • [7] ORAL COOLING (CRYOTHERAPY), AN EFFECTIVE TREATMENT FOR THE PREVENTION OF 5-FLUOROURACIL-INDUCED STOMATITIS
    CASCINU, S
    FEDELI, A
    FEDELI, SL
    CATALANO, G
    [J]. ORAL ONCOLOGY-EUROPEAN JOURNAL OF CANCER PART B, 1994, 30B (04): : 234 - 236
  • [8] Chaveli-Lopez Begonya, 2014, J Clin Exp Dent, V6, pe81, DOI 10.4317/jced.51337
  • [9] Oral mucositis, dysfunction, and distress in patients undergoing cancer therapy
    Cheng, Karis Kin-Fong
    [J]. JOURNAL OF CLINICAL NURSING, 2007, 16 (11) : 2114 - 2121
  • [10] Glutamine decreases interleukin-8 and interleukin-6 but not nitric oxide and prostaglandins E2 production by human gut in-vitro
    Coëffier, M
    Marion, R
    Leplingard, A
    Lerebours, E
    Ducrotté, P
    Déchelotte, P
    [J]. CYTOKINE, 2002, 18 (02) : 92 - 97